Abstract
The neurotrophic factors are proteins that enhance neuronal survival, differentiation, neurotransmitter function and resistance to neurotoxins and lesion. For these reasons the neurotrophic factors are considered as a new potential therapeutic tool for the treatment of neurodegenerative disorders, a group of diseases that produce the most important cause for disability in the Western world. Neurotrophic factors are used in vitro and in vivo models of neurodegenerative disorders. In this context the results of the treatment with neurotrophic factors is very reassuring. Several neurotrophic factors reached the stage of investigation in primate models of neurological disorders and some of them have been used in humans with these diseases. The results so far obtained in humans have been disappointing for several reasons including technical problems for delivery, unbearable side effects or lack of efficacy. Future approaches for the use of neurotrophic factors in humans should include the following: 1. Testing of the putative compounds in animal models more related to the pathophysiology of each disease, such as genetic models of neurodegenerative diseases. 2. New methods of delivery, including genetic engineering by viral vectors and administration through implantation devices. 3. Better methods of testing, including the novel neuroimaging techniques.
Current Medicinal Chemistry - Central Nervous System Agents
Title: Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Volume: 1 Issue: 3
Author(s): J. Garcia de Yebenes and M. P. Sanchez
Affiliation:
Abstract: The neurotrophic factors are proteins that enhance neuronal survival, differentiation, neurotransmitter function and resistance to neurotoxins and lesion. For these reasons the neurotrophic factors are considered as a new potential therapeutic tool for the treatment of neurodegenerative disorders, a group of diseases that produce the most important cause for disability in the Western world. Neurotrophic factors are used in vitro and in vivo models of neurodegenerative disorders. In this context the results of the treatment with neurotrophic factors is very reassuring. Several neurotrophic factors reached the stage of investigation in primate models of neurological disorders and some of them have been used in humans with these diseases. The results so far obtained in humans have been disappointing for several reasons including technical problems for delivery, unbearable side effects or lack of efficacy. Future approaches for the use of neurotrophic factors in humans should include the following: 1. Testing of the putative compounds in animal models more related to the pathophysiology of each disease, such as genetic models of neurodegenerative diseases. 2. New methods of delivery, including genetic engineering by viral vectors and administration through implantation devices. 3. Better methods of testing, including the novel neuroimaging techniques.
Export Options
About this article
Cite this article as:
Garcia de Yebenes J. and Sanchez P. M., Neurotrophic Factors for the Investigation and Treatment of Movement Disorders, Current Medicinal Chemistry - Central Nervous System Agents 2001; 1 (3) . https://dx.doi.org/10.2174/1568015013358446
DOI https://dx.doi.org/10.2174/1568015013358446 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
Related Articles
-
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
Current Neuropharmacology Progressive Brain Damage and Alterations in Dendritic Arborization after Collagenase-Induced Intracerebral Hemorrhage in Rats
Current Neurovascular Research Probiotics Against Viruses; COVID-19 is a Paper Tiger: A Systematic Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design Methodologies to Assess Brain Drug Delivery in Lead Optimization
Current Topics in Medicinal Chemistry High Temporal Resolution Neuroimaging of Attentional and Somatosensory-Motor Processing in the Human Brain
Current Medical Imaging The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Current Pharmaceutical Design Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Effect of Probenecid on the Pain-Related Behaviour and Morphological Markers in Orofacial Formalin Test of the Rat
CNS & Neurological Disorders - Drug Targets Recent Patents on Morphometric Analysis of Eukaryotic Cells
Recent Patents on Medical Imaging Synthesis and Evaluation of Phenyliminoindolin-Containing Phenylacetamide Derivatives with the Antidepressant and Anticonvulsant Effects
Medicinal Chemistry Putting Huntingtin “Aggregation” in View with Windows into the Cellular Milieu
Current Topics in Medicinal Chemistry Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Structural Bases for Substrate and Inhibitor Recognition by Matrix Metalloproteinases
Current Medicinal Chemistry Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Current Medicinal Chemistry Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Aquaporins and Neurodegenerative Diseases
Current Neuropharmacology Study of Convolvulus pluricaulis for Antioxidant and Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry Nitric Oxide in Asthma Therapy
Current Pharmaceutical Design Impact of HIV on Regional & Cellular Organisation of the Brain
Current HIV Research